Search

Your search keyword '"MALAGUTI M"' showing total 369 results
Start Over Author "MALAGUTI M"
369 results on '"MALAGUTI M"'

51. Bio-marcatori e malattia cardio-renale: significato clinico e prognostico

Author

Di Lullo, L., Floccari, F., Rivera, R., Barbera, V., Faiola, R., Feliziani, C., Granata, A., De Pascalis, A., Logias, F., Fiorini, F., Timio, M., Malaguti, M., Santoboni, A., Di Lullo, L., Floccari, F., Rivera, R., Barbera, V., Faiola, R., Feliziani, C., Granata, A., De Pascalis, A., Logias, F., Fiorini, F., Timio, M., Malaguti, M., and Santoboni, A.

Abstract

Cardio-renal syndrome is well – known clinical syndrome, describing both negative effects of impaired renal function on heart and circulation and, on the other hand, those of heart failure on renal function. Many author have investigated the usefulness of serological markers in identify and eventually follow this syndrome. Natriuretic peptides levels are not only directly associated with severity of heart failure, but on the other hand they can help to detect renal dysfunction before creatinine serum levels raise up. NGAL, Cystatin C, NAG, KIM-1 and IL-18 represent interesting biomarkers for early detection of acute kidney injury (AKI), while urinary KIM-1 and urinary IL-18 seems to be appropriate only for differential diagnosis of established AKI., La sindrome cardio-renale (SCR) è una sindrome clinica ben nota, che descrive tanto gli effetti negativi dell'insufficienza renale sull'equilibrio cardio-circolatorio quanto quelli dell'insufficienza cardiaca sulla funzione renale. Molti autori hanno studiato l'utilità di marcatori sierologici ai fini dell'identificazione e del monitoraggio ambulatoriale delle varie forme di questa sindrome. L'analisi dei livelli sierici dei peptidi natriuretici è, al momento, quella maggiormente utilizzata, in quanto essi stessi non sono solo direttamente associati alla gravità delhinsufficienza cardiaca, ma anche capaci di rilevare precocemente la disfunzione renale, certamente prima che sia possible osservare un incremento nei livelli sierici di creatinina. NGAL, cistatina C, NAG, KIM-1 e IL-18 rappresentano interessanti biomarcatori per la diagnosi precoce di danno renale acuto (AKI), e quindi per la diagnosi precoce delle forme renocardiache acute, mentre il loro utilizzo in altre forme di SCR non appare codificato. Al contrario, la valutazione di KIM-1 e IL-18 sembra più utile per cercare una diagnostica differenziale tra forme diverse di insufficienza renale acuta.

Published
2018

52. L'eritropoietina e la cardiopatia ischemica: un nuovo attore tra apoptosi e angiogenesi cardiovascolare

Author

Floccari, F., Di Lullo, L., Polito, P., Malaguti, M., Buemi, M., Floccari, F., Di Lullo, L., Polito, P., Malaguti, M., and Buemi, M.

Abstract

L'eritropoietina, per molti anni intesa unicamente come principale regolatore della massa eritrocitaria circolante, ha svelato nel corso degli anni sempre nuove pagine di fisiologia, che l'hanno mostrata come elemento centrale di un complesso sistema che mantiene l'equilibrio tra ossigenazione periferica, stabilità vascolare e stress ossidativo. Al crescere delle conoscenze sulla fisiologia autocrina e paracrina dell'EPO, sono cresciute le aspettative verso l'utilizzo clinico-pratico di tali conoscenze. La presente review propone una rapida carrellata sulle diverse potenziali applicazioni dell'EPO nel management clinico della cardiopatia ischemica, con particolare riguardo alle strategie testate per ottenere gli effetti pleiotropici dell'EPO senza indurre indesiderati incrementi dell'ematocrito., No abstract

Published
2018

54. La fistola arterovenosa e lo scompenso ad alta gittata: un tema di grande… portata

Author

Floccari, F., Di Lullo, L., Rivera, R., Malaguti, M., Santoboni, A., Granata, A., Timio, M., Floccari, F., Di Lullo, L., Rivera, R., Malaguti, M., Santoboni, A., Granata, A., and Timio, M.

Abstract

A fair number of scientific studies have investigated possible links between arteriovenous fistulas and heart failure, in some cases with consolidated results but in some cases with conflicting results. Other issues, such as right heart failure, were investigated in a marginal way. This survey presents a quick overview of the literature in recent years and raises some outstanding questions on cardionefrologia., Un discreto numero di lavori scientifici ha indagato i possibili nessi esistenti tra fistole arterovenose e scompenso cardiaco, con risultati in parte assolutamente consolidati ed in altra parte contrastanti. Altri temi, come lo scompenso del cuore destro, risultano indagati in maniera marginale. Questa rassegna presenta un rapido excursus della letteratura degli ultimi anni e solleva alcuni interrogativi insoluti in materia di cardionefrologia.

Published
2018

56. Aeteriovenous Fistula and Heart Failure: Can the Flow Become an Issue?

Author

Floccari, F., Di Lullo, L., Rivera, R., Malaguti, M., Santoboni, A., Granata, A., Timio, M., Floccari, F., Di Lullo, L., Rivera, R., Malaguti, M., Santoboni, A., Granata, A., and Timio, M.

Abstract

A fair number of scientific studies have investigated possible links between arteriovenous fistulas and heart failure, in some cases with consolidated results but in some cases with conflicting results. Other issues, such as right heart failure, were investigated in a marginal way. This survey presents a quick overview of the literature in recent years and raises some outstanding questions on cardionefrologia. (Cardionephrology), Un discreto numero di lavori scientifici ha indagato i possibili nessi esistenti tra fistole arterovenose e scompenso cardiaco, con risultati in parte assolutamente consolidati ed in altra parte contrastanti. Altri temi, come lo scompenso del cuore destro, risultano indagati in maniera marginale. Questa rassegna presenta un rapido excursus della letteratura degli ultimi anni e solleva alcuni interrogativi insoluti in materia di cardionefrologia. (Cardionephrology)

Published
2018

57. Erythropoietin and ischemic heart disease: a new player between apoptosis and cardiovascular angiogenesis

Author

Floccari, F., Di Lullo, L., Polito, P., Malaguti, M., Buemi, M., Floccari, F., Di Lullo, L., Polito, P., Malaguti, M., and Buemi, M.

Abstract

No abstract, L'eritropoietina, per molti anni intesa unicamente come principale regolatore della massa eritrocitaria circolante, ha svelato nel corso degli anni sempre nuove pagine di fisiologia, che l'hanno mostrata come elemento centrale di un complesso sistema che mantiene l'equilibrio tra ossigenazione periferica, stabilità vascolare e stress ossidativo. Al crescere delle conoscenze sulla fisiologia autocrina e paracrina dell'EPO, sono cresciute le aspettative verso l'utilizzo clinico-pratico di tali conoscenze. La presente review propone una rapida carrellata sulle diverse potenziali applicazioni dell'EPO nel management clinico della cardiopatia ischemica, con particolare riguardo alle strategie testate per ottenere gli effetti pleiotropici dell'EPO senza indurre indesiderati incrementi dell'ematocrito.

Published
2018

58. Pericardial Involvement in CKD Patients

Author

Di Lullo, L., Floccari, F., Rivera, R., Bellasi, A., Ferramosca, E., De Pascalis, A., Timio, M., Malaguti, M., Santoboni, A., Di Lullo, L., Floccari, F., Rivera, R., Bellasi, A., Ferramosca, E., De Pascalis, A., Timio, M., Malaguti, M., and Santoboni, A.

Abstract

Patients with Chronic Kidney Disease may present all typical pericardial clinical entities but some of them are surely more common than others. Last decades have witnessed to a dramatic improvement in caring patients with kidney failure and uremic pericarditis (as seen in the past) is quite rare to observe. Pericardial effusion (idiopathic or secondary) is more frequent, especially in hemodialysis patients and in those patients who start renal replacement therapy in critical care conditions (i.e. patients with chronic and or acute heart failure). In CKD patients following clinical conditions can be present: pericardial effusion (idiopathic or secondary), acute pericarditis, constrictive pericarditis. Pericardial effusion can be classified as mild, moderate or severe; acute pericarditis could be idiopathic or secondary to wide spectrum of infectious, immunologic or neoplastic diseases. Constrictive pericarditis can represent final pathway of many secondary conditions leading to pericardic and myocardic fibrosis.  (Cardionephrology), I pazienti affetti da malattia renale cronica possono andare incontro a tutta una serie di patologie che colpiscono il pericardio ma, sicuramente, alcune entità nosologiche sono più frequenti di altre. Gli ultimi decenni hanno assistito, per fortuna nostra e dei nostri pazienti, a un netto miglioramento per quanto concerne i protocolli terapeutici per i pazienti nefropatici e le forme tipiche di pericardite uremica, così frequenti negli anni passati, sono ormai uno sbiadito ricordo. È tuttora frequente osservare pazienti con versamento pericardico (idiopatico, ovvero secondario a malattie sistemiche), soprattutto per quanto concerne i pazienti sottoposti a trattamenti depurativi extracorporei ed i pazienti che iniziano il trattamento dialitico in condizioni di emergenza/urgenza (ad esempio, pazienti affetti da scompenso cardiaco congestizio); il versamento pericardico viene schematicamente classificato in lieve, moderato e severo in base all'interessamento più o meno globale del pericardio. Meno frequenti sono gli episodi di pericardite acuta (anch'essa idiopatica o secondaria), spesso su base virale, neoplasticae/o immunologica (vedi pazienti trapiantati in terapia immunosoppressiva). Le forme di pericardite costrittiva sono più rare a documentarsi in corso di malattia renale cronica e, in genere, rappresentano lo stadio finale di diverse patologie sistemiche: l'esito finale è, in genere, la fibrosi pericardica. (Cardionephrology)

Published
2018

60. Chronic kidney disease and congestive heart failure management: cardionephrologist's role

Author

Rivera, R., Floccari, F., Di Lullo, L., Granata, A., Logias, F., D’Amelio, A., Fiorini, F., Sala, V., Villani, A., Malaguti, M., Santoboni, A., Timio, M., Rivera, R., Floccari, F., Di Lullo, L., Granata, A., Logias, F., D’Amelio, A., Fiorini, F., Sala, V., Villani, A., Malaguti, M., Santoboni, A., and Timio, M.

Abstract

Kidney is mainly involved in fluid and electrolytes homeostasis, as well as in toxins knockout. Kidney function seems to be strictly related to heart and cardiovascular asset and ‘cardiorenal syndrome’ is now used to identify clinical correlation between heart and kidney disease. Chronic heart failure (CHF) represent first cause of hospitalization in western countries; CHF patients often present with mild to severe chronic kidney disease (CKD). Many physiological and pathophysiological pathways are postulated to explain how CKD can affect CHF prognosis and vice-versa. cGMP and NO - cGMP axis could be involved in pathogenesis of CHF in CKD patients together with natriuretic peptides (ANP and BNP) and phosphodiesterases control. Patients with CHF need to be treated for their chronic volume overload. First choice therapy is undoubtedly diuretic therapy, often with association between different kinds of drugs (such as thiazides and loop diuretics). Ultrafiltration excorporeal treatments are usually indicated in those patients not responding to massive diuretic treatments and they are often employed as complementary treatment in patients with refractory CHF.  (Cardionephrology), Il rene è coinvolto, in prima battuta, nel mantenimento dell'omeostasi dei fluidi e dell'equilibrio idro-elettrolitico ed acido-base, nonché nell'eliminazione delle scorie tossiche. La funzione renale sembra essere strettamente collegata a quella cardiovascolare e, negli ultimi anni, il termine di ‘sindrome Cardio-Renale’ è stato utilizzato per spiegare le correlazioni cliniche tra patologia renale e cardiaca. Lo scompenso cardiaco congestizio (SCC) rappresenta la prima causa di ospedalizzazione nei Paesi occidentali e i pazienti affetti presentano spesso, in associazione, un quadro di malattia renale cronica (MRC) di grado variabile. Sono stati considerati diversi modelli fisiologici e fisiopatologici per spiegare come una condizione di malattia renale cronica possa influenzare lo stato di insufficienza cardiaca. Sicuramente la via metabolica del guanosin monofosfato ciclico (cGMP) e quello dell'ossido nitrico (NO) giocano un ruolo fondamentale di concerto con l'azione dei peptidi natriuretici atrial natriuretic peptide (ANP) e brain natriuretic peptide (BNP) sotto il controllo del sistema delle fosfodiesterasi sieriche. I pazienti con sovraccarico di circolo necessitano di terapie farmacologiche specifiche. La terapia diuretica, spesso in associazione (vedi tiazidici + diuretici d'ansa), rappresenta ancora quella di prima scelta ma, nei pazienti, refrattari alla terapia diuretica a dosi massimali, l'impiego di metodiche extracorporee, quali l'ultrafiltrazione (nelle sue diverse modalità d'impiego), può essere di grande aiuto per il paziente scompensato dal punto di vista cardiologico.  (Cardionephrology)

Published
2018

61. Bio-Markers and Cardiorenal Disease: Prognostic and Clinical Relevance

Author

Di Lullo, L., Floccari, F., Rivera, R., Barbera, V., Faiola, R., Feliziani, C., Granata, A., De Pascalis, A., Logias, F., Fiorini, F., Timio, M., Malaguti, M., Santoboni, A., Di Lullo, L., Floccari, F., Rivera, R., Barbera, V., Faiola, R., Feliziani, C., Granata, A., De Pascalis, A., Logias, F., Fiorini, F., Timio, M., Malaguti, M., and Santoboni, A.

Abstract

Cardio-renal syndrome is well – known clinical syndrome, describing both negative effects of impaired renal function on heart and circulation and, on the other hand, those of heart failure on renal function. Many author have investigated the usefulness of serological markers in identify and eventually follow this syndrome. Natriuretic peptides levels are not only directly associated with severity of heart failure, but on the other hand they can help to detect renal dysfunction before creatinine serum levels raise up. NGAL, Cystatin C, NAG, KIM-1 and IL-18 represent interesting biomarkers for early detection of acute kidney injury (AKI), while urinary KIM-1 and urinary IL-18 seems to be appropriate only for differential diagnosis of established AKI. (Cardionephrology), La sindrome cardio-renale (SCR) è una sindrome clinica ben nota, che descrive tanto gli effetti negativi dell'insufficienza renale sull'equilibrio cardio-circolatorio quanto quelli dell'insufficienza cardiaca sulla funzione renale. Molti autori hanno studiato l'utilità di marcatori sierologici ai fini dell'identificazione e del monitoraggio ambulatoriale delle varie forme di questa sindrome. L'analisi dei livelli sierici dei peptidi natriuretici è, al momento, quella maggiormente utilizzata, in quanto essi stessi non sono solo direttamente associati alla gravità delhinsufficienza cardiaca, ma anche capaci di rilevare precocemente la disfunzione renale, certamente prima che sia possible osservare un incremento nei livelli sierici di creatinina. NGAL, cistatina C, NAG, KIM-1 e IL-18 rappresentano interessanti biomarcatori per la diagnosi precoce di danno renale acuto (AKI), e quindi per la diagnosi precoce delle forme renocardiache acute, mentre il loro utilizzo in altre forme di SCR non appare codificato. Al contrario, la valutazione di KIM-1 e IL-18 sembra più utile per cercare una diagnostica differenziale tra forme diverse di insufficienza renale acuta. (Cardionephrology)

Published
2018

62. L’esperienza dell’arbitrato nell’ambito della finanza internazionale

Author

AA VV, Malaguti, Maria Chiara, MALAGUTI M (ORCID:0000-0003-2445-8529), AA VV, Malaguti, Maria Chiara, and MALAGUTI M (ORCID:0000-0003-2445-8529)

Abstract

financial disputes rarely go into arbitration. The contribution indicates reasons for this and possible developments for the future. Investment arbitration is also reported

Published
2018

63. amicus curiae e tutela del public interest: spazi per una nuova cultura giuridica?

Author

BILOTTI E, FARACE D, MALAGUTI M, Malaguti, Maria Chiara, MALAGUTI M (ORCID:0000-0003-2445-8529), BILOTTI E, FARACE D, MALAGUTI M, Malaguti, Maria Chiara, and MALAGUTI M (ORCID:0000-0003-2445-8529)

Abstract

the institution of amicus curiae permits the consideration of interests and stakeholders that are excluded from the proceedings. This might give rise to a new consideration of third parties interests in disputes and in international assessment of rights

Published
2015

64. [Best practices on peritoneal dialysis: the audit of Lazio Region]

Author

Morosetti, M., Ansali, F., Malaguti, M., Lanzetta, R., Di Giulio, S., Domenici, A., Mene, P., Rocca, A. R., Cerroni, F., Valentini, W., Filippini, A., Musone, D., Rosa, M., Tomei, V., De Gennaro, F., Brambilla, M., and Cogliati, P.

Subjects
indicatori, questionario, dialisi peritoneale, Benchmarking, Medical Audit, protocolli, Italy, best practice, Humans, Kidney Failure, Chronic, audit, Peritoneal Dialysis
Abstract

The diffusion of peritoneal methodology can not be something out of the real organizational context and the regional directive can not be the only means to encourage the diffusion. There is the need to provide effective and sustainable levels of assistance through a clinical scientific support and sharing of best-practises. On one side, the aim is to provide an aid by the centers with great expertise in the methodology, recognized as reference points; on the other side, to establish the shared K.P.I.s (Key Performance Index), to asses the clinical effectiveness and measure the objectives to be achieved, through a modality of valuation to establish the real applicability. For this purpose, a scientific board was founded, composed by the heads of UU.OO, that provide the peritoneal dialysis, to determine which aspects to investigate and identify factors of supply improvement. The selected method was the clinical audit. The analysis of the 2011 data has allowed us to capture the situation of the peritoneal dialysis in the Lazio Region. The formative procedure has enabled the centers to share and standardize protocols and therapeutic procedures, identify the strengths of peritoneal dialysis in the Lazio Region and define the KPIs through whose compare and monitor the centers over time. The conclusive analysis of the audit has enabled to identify a series of activities to be undertaken together in order to improve the situation of the peritoneal dialysis in the Lazio Region. In the following years, surveys will be carried out to verify the KPIs trend.

Published
2017

65. Guía Legislativa de UNIDROIT sobre Valores Intermediados

Author

Kanda, H., Dupont, P., Einsele, D., Garcimartín Alférez, F., Goutay, P., Keijser, T.R.M.P., Malaguti, M., Mooney, C., Thévenoz, L., and Wu, J.

Subjects
Overig (niet-programmatisch) onderzoek
Abstract

Contains fulltext : 186024.pdf (Publisher’s version ) (Closed access) 196 p.

Published
2017

66. Guide législatif d’UNIDROIT sur les titres intermédiés

Author

Kanda, H., Dupont, P., Einsele, D., Garcimartín Alférez, F., Goutay, P., Keijser, T.R.M.P., Malaguti, M., Mooney, C., Thévenoz, L., and Wu, J.

Subjects
Overig (niet-programmatisch) onderzoek
Abstract

Contains fulltext : 179195pub.pdf (Publisher’s version ) (Closed access) 185 p.

Published
2017

67. UNIDROIT Legislative Guide on Intermediated Securities

Author

Kanda, H., Dupont, P., Einsele, D., Garcimartín Alférez, F., Goutay, P., Keijser, T.R.M.P., Malaguti, M., Mooney, C., Thévenoz, L., and Wu, Jing

Subjects
Finance, Security and Insolvency Law, Financiering, zekerheden en insolventie, GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries)
Abstract

Contains fulltext : 180049pub.pdf (Publisher’s version ) (Open Access) 178 p.

Published
2017

69. Bio-marcatori e malattia cardio-renale: significato clinico e prognostico

Author

Di Lullo, L., primary, Floccari, F., additional, Rivera, R., additional, Barbera, V., additional, Faiola, R., additional, Feliziani, C., additional, Granata, A., additional, De Pascalis, A., additional, Logias, F., additional, Fiorini, F., additional, Timio, M., additional, Malaguti, M., additional, and Santoboni, A., additional

Published
2018
Full Text
View/download PDF

77. 'Sviluppo' e diritto internazionale dell'economia

Author

TRIGGIANI E, CHERUBINI F, INGRAVALLO I, NALIN, VIRZO, Malaguti, Maria Chiara, MALAGUTI M (ORCID:0000-0003-2445-8529), TRIGGIANI E, CHERUBINI F, INGRAVALLO I, NALIN, VIRZO, Malaguti, Maria Chiara, and MALAGUTI M (ORCID:0000-0003-2445-8529)

Abstract

rethinking the dichotomy between international economic law and development

Published
2017

78. La responsabilità sociale d'impresa - Percorsi interpretativi tra casi e materiali di diritto internazionale, dell'Unione europea ed italiano

Author

Malaguti, M. (ORCID:0000-0003-2445-8529), Salvati, G. (ORCID:0000-0002-9931-6800), Malaguti, M. (ORCID:0000-0003-2445-8529), and Salvati, G. (ORCID:0000-0002-9931-6800)

Abstract

the book discusses all developments of companies social responsibility through international and domestic sources, both hard and soft law. It also includes case law coming from ADR and arbitration

Published
2017

79. Politiche antitrust ieri, oggi e domani.

Author

Malaguti M. C. (ORCID:0000-0003-2445-8529), Oglio L., Vanoni S. (ORCID:0000-0001-5371-1023), Malaguti, Maria Chiara, Oglio, Livia, Vanoni, Silvia, Malaguti M. C. (ORCID:0000-0003-2445-8529), Oglio L., Vanoni S. (ORCID:0000-0001-5371-1023), Malaguti, Maria Chiara, Oglio, Livia, and Vanoni, Silvia

Abstract

Il volume raccoglie gli atti del convegno tenutosi presso l'Università Cattolica del S.C. di Milano nel maggio 2016 per celebrare i venti anni dell'iniziativa dei seminari "I venerdì dell'antitrust". esso raccoglie i contributi di autorevoli studiosi ed operatori nell'ambito del diritto della concorrenza, che hanno offerto un panorama delle questioni più attuali e spinose che devono essere affrontate nello studio teorico e nella pratica della disciplina in questione, punto d'incontro tra economia e diritto, e potenziale strumento di orientamento dell'economia interna e comunitaria.

Published
2017

80. Neuroprotective effects of sulforaphane on methylglyoxal-induced glycation in SH-SY5Y cell line

Author

Angeloni, Cristina, Barbalace, Mc, Rizzo, B, Fabbri, D, Malaguti, M, Hrelia, S., Federazione Italiana Scienze della Vita, Angeloni C, Barbalace MC, Rizzo B, Fabbri D, Malaguti M, and Hrelia S

Subjects
NEUROPROTECTION, SULFORAPHANE, NON ENZYMATIC GLYCATION
Abstract

Glycation, an endogenous process that leads to the production of advanced glycation end products (AGEs), plays a role in the etiopathogenesis of Alzheimer's disease (AD). Methylglyoxal (MG) is the most potent precursor of AGEs. It has been demonstrated that AGEs cause a reduction in brain derived neurotrophic factor protein (BDNF), whose dysregulation is related to AD development. Sulforaphane (SF), an isothiocyanate found in Cruciferous vegetables, is known for its chemopreventive, cardioprotective and neuroprotective actions. Aim of this study was to investigate the role of SF in counteracting MG induced damage in SH-SY5Y neuroblastoma cells. SF counteracted MG- induced neuronal death and apoptosis as measured by MTT assay, LDH release and caspase 3 activity. SF significantly reduced intracellular ROS and increased GSH levels in MG treated cells. SF inhibited the phosphorylation of the pro-apoptotic MAPK kinases induced by MG, increased the expression and the activity of the detoxifying glyoxalase enzymes GLO1 and GLO2 and increased BDNF expression of BDNF, demonstrating a pleiotropic role in counteracting AD. This work was supported by MIUR-FIRB (project RBAP11HSZS)

Published
2014

82. Pathophysiology and diagnosis of cardio-renal syndrome: actual picture and future prospectives

Author

Di Lullo L, Floccari F, De Pascalis A, Marinelli A, Barbera V, Santoboni A, Malaguti M, Balducci A, Russo D, Rivera R, Gorini A, Claudio Ronco, Di Lullo, L, Floccari, F, De Pascalis, A, Marinelli, A, Barbera, V, Santoboni, A, Malaguti, M, Balducci, A, Russo, Domenico, Rivera, R, Gorini, A, and Ronco, C.

Subjects
Acute kidney injury, Biomarkers, Cardio – Renal Syndrome, Chronic Kidney Disease, Echocardiography, Heart failure, Kidney Ultrasound
Abstract

Pathophysiology and Diagnosis of Cardio-renal Syndrome: Actual Picture and Future Prospectives The cardio–renal syndrome (CRS) indicates how close the relationship is between heart and kidney during failure of these organs. At present, the classification of the syndrome includes five types of CRS: types I and II which are strictly related to initial heart failure (both acute and chronic), types III and IV which include initial kidney failure, and type V which includes several systemic diseases. Many pathophysiological pathways have been described illustrating how heart and kidney disease are involved in clinical conditions. The diagnosis of CRS is based on both blood tests and ultrasound imaging. Several biomarkers indicating levels of heart and kidney function have emerged over the last few decades which can be used to predict kidney failure in patients with acute or chronic heart disease. Kidney injury biomarkers have also to be tested, especially those indicating glomerular and tubular damage. Renal ultrasound and trans-thoracic echocardiography can provide further information on heart and kidney failure in patients with cardio-renal syndrome at any stage.

Published
2013

83. Lazio dialysis registry: natives vs foreigners

Author

Di Napoli, A, Lapucci, E, Baglio, G, Di Giulio, S, Addessi, M, Alfarone, C, Amoroso, F, Apollinari, E, Baldinelli, G, Baldinelli, M, Barbera, G, Barone, P, Bartolomucci, M, Basili, A, Battista, M, Beraldi, M, Boccia, E, Bruno, F, Buono, A, Canulla, C, Capobianco, L, Caschera, M, Castellano, F, Chamoun, G, Cherubini, C, Chiappini, M, Ciano, G, Costantini, S, Cuzziol, C, Darida, S, Dascal, M, De Bella, E, De Caro, M, De Cicco, C, De Fazio, S, de Virgiliis, G, Della Grotta, F, Della Rovere, F, Di Daniele, N, Di Legge, R, Di Toro Mammarella, R, Dominijanni, S, Esposto, G, Fabozzi, G, Falcone, C, Faraglia, F, Felice, C, Felicioni, R, Feriozzi, S, Ferrari, I, Filippini, A, Fini, R, Firmi, G, Flammini, A, Floccari, F, Forte, F, Galli, D, Galliani, M, Gamberoni, M, Gargiulo, A, Giordano, N, Giustini, A, Grimaldi, R, Hassan, S, Iacono, R, Iamundo, V, Kristuli, L, Laino, M, Leoni, M, Lonzi, M, Lucchetta, F, Maggesano, V, Malaguti, M, Mangeri, M, Marinelli, A, Marinelli, R, Marsili, F, Mauro, L, Mazzaferro, S, Meconizzi, M, Melillo, F, Merigliano, V, Messia, A, Morabito, S, Morosetti, M, Murrone, P, Muzi, L, Nacca, R, Nardone, P, Naticchia, A, Nazzaro, L, Nigro, A, Noce, A, Ordonez, D, Pace, G, Palombo, R, Pantano, L, Panzieri, G, Paone, A, Paparella, M, Pasquarelli, C, Pelosi, M, Petroni, S, Picca, S, Polidori, L, Polito, P, Principe, F, Pulcinelli, G, Puliti, M, Punzo, G, Retico, E, Rifici, N, Riveruzzi, P, Rodriguez, I, Rossi, V, Rossini, B, Santoboni, A, Sfregola, P, Simeoni, P, Simonelli, R, Solazzo, A, Spagnolini, A, Spaziani, M, Splendiani, G, Staffolani, E, Startari, S, Steri, P, Sturniolo, A, Tazza, L, Torre, M, Treglia, A, Triolo, L, Tuderti, F, Tulli, U, Turchetta, L, Valentini, W, Vancini, C, Vastano, S, Vega, A, Ventola, F, Veronese, P, Villani, A, Violi, F, Vitaliano, E, Zanfoni, C, Zazzaro, D, and Zugaro, A

Subjects
Male, Survival Rate, Settore MED/14 - Nefrologia, Italy, Renal Dialysis, Emigrants and Immigrants, Humans, Female, Registries, Middle Aged, Aged
Abstract

An increasing number of foreigners was observed in Italy even among chronic dialysis patients. We compared demographic, clinical, treatment characteristics and survival probability between groups of Italian and foreign patients with chronic dialysis in Lazio.We analysed data from the Lazio Dialysis and Transplantation Registry from 2004 to 2012 (4,076 prevalent chronic dialysis patients in 31-12-2012). Among 7,970 incident patients, we evaluated, by country of birth, survival probability by using Kaplan-Meier method and mortality risk, through multiple Cox regression.We observed an increase of foreigners among chronic dialysis patients in Lazio from 2004 (4.4%) up to 2012 (7.6%, test for trend: p0,001). Compared with Italians, foreign patients were younger (53.816.3 vs. 68.713.6) and more frequently: women (42.7% vs. 37.7%), HbsAg-positive (18.1% vs. 13.9%), not vaccinated if HBV susceptible (26.8% vs. 20.9%), late referral (21.6% vs. 12.9%) and suitable for kidney transplantation (21.7% vs. 9.9%). Foreigners compared with Italians had higher survival probability at 1 year (91.9% vs. 84.7%) and 5 years (74,6% vs. 51,5%) after chronic dialysis has been started. We observed a lower mortality risk (HR=0.71;IC95%:0.58-0.87) among foreign patients even after adjustment for many potential confounding factors. Our findings suggest that health status and treatment of end stage renal disease, including access to kidney transplantation, were similar between groups of Italian and foreign patients in Lazio. Observed differences in patients' characteristics were probably attributable to younger age of foreigners. However, further analyses are needed to fully explain higher survival probability in chronic dialysis among foreigners compared with Italians.

Published
2015

84. Echocardiography in nephrology

Author

Di Lullo L, Granata Antonio, Logias F, Fiorini F, D'Amelio A, Zamboli P, Malaguti M, Santoboni A, Floccari F, Di Lullo, L, Granata, A, Logias, F, Fiorini, F, D'Amelio, A, Zamboli, Pasquale, Malaguti, M, Santoboni, A, and Floccari, F.

Published
2012

85. excesses in the remuneration of directors of limited companies and the UNIDROIT Principles

Author

AA.VV., Malaguti, Maria Chiara, Salvati, Giovanna, MALAGUTI M (ORCID:0000-0003-2445-8529), SALVATI G (ORCID:0000-0002-9931-6800), AA.VV., Malaguti, Maria Chiara, Salvati, Giovanna, MALAGUTI M (ORCID:0000-0003-2445-8529), and SALVATI G (ORCID:0000-0002-9931-6800)

Abstract

application of the UNIDROIT principles to a specific issue of company governance

Published
2016

86. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study

Author

Gallieni, M., De Luca, N., Santoro, D., Meneghel, G., Formica, M., Grandaliano, Giuseppe, Pizzarelli, F., Cossu, M., Segoloni, G., Quintaliani, G., Di Giulio, S., Pisani, A., Malaguti, M., Marseglia, C., Oldrizzi, L., Pacilio, M., Conte, G., Dal Canton, A., Minutolo, R., Grandaliano G. (ORCID:0000-0003-1213-2177), Gallieni, M., De Luca, N., Santoro, D., Meneghel, G., Formica, M., Grandaliano, Giuseppe, Pizzarelli, F., Cossu, M., Segoloni, G., Quintaliani, G., Di Giulio, S., Pisani, A., Malaguti, M., Marseglia, C., Oldrizzi, L., Pacilio, M., Conte, G., Dal Canton, A., Minutolo, R., and Grandaliano G. (ORCID:0000-0003-1213-2177)

Abstract

Background: Knowledge about mineral bone disorder (MBD) management in non-dialysis chronic kidney disease (ND-CKD) patients is scarce, although essential to identifying areas for therapeutic improvement. Methods: We prospectively evaluated current management of CKD-MBD in two visits, performed 6 months apart, in 727 prevalent ND-CKD stage 3b–5 patients from 19 nephrology clinics. Therapeutic inertia was defined as lack of treatment despite hyperphosphatemia and/or hypocalcemia, and/or hyperparathyroidism. The primary endpoint was the prevalence of achieved target for CKD-MBD parameters and related treatments (phosphate binders, vitamin D and calcium supplements). The secondary endpoint was the assessment of prevalence and clinical correlates of therapeutic inertia. Results: Over 65 % of patients did not reach parathormone (PTH) targets, while 15 and 19 % did not reach phosphate and calcium targets, respectively. The proportion of untreated patients decreased from stage 3b to 5 (at baseline, from 60 to 16 %, respectively). From baseline to the 6-month visit, the achievement of targets remained stable. Low protein diet was prescribed in 26 % of patients, phosphate binders in 17.3 % (calcium-based binders 15.5 %, aluminium binders 1.8 %), and vitamin D in 50.5 %. The overall prevalence of therapeutic inertia at the 6-month visit was 34.0 % (for hyperphosphatemia, 54.3 %). Compared to CKD stage 3, the likelihood of therapeutic inertia was 40 and 68 % lower at stage 4 and 5, respectively. Conclusions: PTH, calcium and phosphate targets were not reached in a significant proportion of patients. One-third of patients with at least one MBD parameter not-at-target remained untreated. Therapeutic inertia regarding CKD-MBD treatment may be a major barrier to optimizing the prevention and cure of CKD-MBD.

Published
2016

87. Abitudini alimentari, infiammazione e stress ossidativo in un campione di soggetti anziani: risultati dello studio Europeo 'RISTOMED' - New E-Services for a dietary approach to the elderly (FP 7 - SME - 2007 – 1; Grant 222230)

Author

Pinto, Alessandro, Hrelia, S., Rosano, Aldo, DE STEFANO, D., Asprino, Rosa, Toselli, Lucia, Malaguti, M., Hrelia, P., Valentini, L., BOURDEL MARCHASSON, I., Buccolini, F., Pryen, F., D’Alessio, P., Lochs, H., Franceschi, C., and Ostan, R.

Subjects
stress ossidativo, invecchiamento, pattern alimentare, infiammazione, malattie cronico-degenerative
Published
2014

88. Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics

Author

Dal Canton, ., Esposito, V., Formica, M., Segoloni, G., Gallieni, M., Locatelli, F., Tarchini, R., Meneghel, G., Oldrizzi, L., Cossu, M., Di Giulio, S., Malaguti, M., Pizzarelli, F., Quintaliani, G., Cianciaruso, B., Pisani, A., Conte, G., De Nicola, L., Minutolo, R., Bonofiglio, R., Fuiano, G., Grandaliano, G., Bellinghieri, Guido, Santoro, Domenico, Minutolo, Roberto, Locatelli, F, Gallieni, M, Bonofiglio, R, Fuiano, G, Oldrizzi, L, Conte, Giuseppe, DE NICOLA, Luca, Mangione, F, Esposito, P, Dal Canton, A, and REport of COmorbidities in non Dialysis Renal Disease Population in Italy Study, Group

Subjects
Nephrology, Male, medicine.medical_specialty, Anemia, medicine.medical_treatment, Iron, Renal function, Hemoglobins, Renal Dialysis, hemic and lymphatic diseases, Internal medicine, medicine, Clinical endpoint, Prevalence, Humans, Prospective Studies, Renal Insufficiency, Chronic, Erythropoietin, Aged, Transplantation, Transferrin saturation, business.industry, Iron deficiency, medicine.disease, Italy, Dietary Supplements, Ferritins, Female, Hemodialysis, business, Kidney disease
Abstract

Background: Knowledge on anaemia management in non-dialysis chronic kidney disease (ND-CKD) patients regularly followed in renal clinics is scarce although being essential to identifying areas of therapeutic improvement. Methods: We prospectively evaluated anaemia management in two visits, performed 6 months apart, in 755 prevalent ND-CKD stage 3b-5 patients followed in 19 nephrology clinics from ≥6 months. Anaemia was defined as severe (Hb

Published
2013

91. ELECTROPHYSIOLOGY IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY WITH IGIV

Author

Bril, V, Katzberg, H, Donofrio, P, Banach, M, Dalakas, Mc, Deng, C, Hanna, K, Hartung, Hp, Hughes, Ra, Latov, N, Merkies, Is, van Doorn, Pa, Ice, Sg, Adamova, B, Apostolski, S, Artamonov, I, Barroso, F, Bartosik Psujek, H, Basta, I, Bednarik, J, Belniak, E, Benedetti, L, Bogucki, A, Bojar, M, Buchman, A, Caress, J, Chapman, J, Chapman, K, Cho, S, Chyrchel, U, Comi, G, Dacci, P, Del Carro, U, Divac, V, Drory, V, Dubrovsky, A, Ehler, E, Fazio, R, Fryze, W, Fulgenzi, E, Ghiglione, E, Grandis, Marina, Gonzalez Cornejo, S, Gonzalez Jaime, J, Groozman, G, Haas, J, Kaminski, M, Kostera Pruszczyk, A, Kwiecinski, H, Lautre, A, Malaguti, M, Marchesoni, C, Munch, C, Narciso, E, Nations, S, Nogués, M, Oh, S, Pardal, A, Patwa, H, Pavlovic, S, Pozdzik Koseda, A, Reisin, R, Rivero, A, Romero Vargas, S, Ruiz Sandoval, J, Schenone, Angelo, Selmaj, K, Stelmasiak, Z, Swaitkiewicz, J, Szadkowska, I, Szczudlik, A, Thomas, F, Trikic, R, Trivedi, J, Tsao, B, Uncini, A, Villa, A, Vohanka, S, Wolfe, G, Zielinska, M., and Neurology

Subjects
medicine.medical_specialty, Physiology, Neural Conduction, Motor nerve, Action Potentials, Chronic inflammatory demyelinating polyneuropathy, Placebo, Gastroenterology, law.invention, Placebos, Cellular and Molecular Neuroscience, Randomized controlled trial, law, Physiology (medical), Internal medicine, medicine, Humans, Immunologic Factors, Motor Neurons, Chromatography, Leg, Cross-Over Studies, business.industry, Electrodiagnosis, Immunoglobulins, Intravenous, Polyradiculoneuropathy, medicine.disease, Crossover study, Confidence interval, Surgery, medicine.anatomical_structure, Treatment Outcome, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Arm, Neurology (clinical), Caprylates, business, Sensory nerve
Abstract

Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) received immune globulin intravenous, 10% caprylate/chromatography purified (IGIV-C, Gamunex; n = 59) or placebo (n = 58) every 3 weeks for up to 24 weeks (first period) in a randomized, double-blind, parallel-group, response-conditional, crossover study. Motor and sensory nerves were assessed at baseline and endpoint/week 24. A nonsignificant trend toward improvement in the proximal amplitude of the most severely affected motor nerve was observed with IGIV-C (0.69 +/- 1.86 mV) versus placebo (0.47 +/- 2.29 mV), and a greater improvement of 1.08 +/- 2.15 mV with IGIV-C versus 0.46 +/- 2.03 mV with placebo (P = 0.089) was observed with exclusion of data from Erb's point stimulation. Greater improvements from baseline favoring IGIV-C were observed for 127/142 electrophysiologic parameters. The averaged motor amplitudes from all motor nerves significantly improved with IGIV-C versus placebo [treatment difference, 0.62 mV; 95% confidence interval (CI), 0.05, 1.20; P = 0.035], and conduction block decreased significantly (treatment difference, -5.54%; 95% CI, -10.43, -0.64; P = 0.027), particularly in the lower limbs. Overall, the data suggest that IGIV-C improves electrophysiologic parameters in CIDP.

Published
2009

93. Quality of life and disability assessment in neuropathy: a multicenter study

Author

Padua, L, Schenone, A, Aprile, I, Benedetti, L, Caliandro, P, Tonali, P, NOBILE ORAZIO, E, Cardinali, P, Forconesi, F, Cocito, D, Isoardo, G, Giannini, F, Bibbo’, G, Fazio, R, Malaguti, M, Gemignani, F, Insola, A, Bove, R, Murasecco, D, Romano, M, Cottone, S, Pareyson, D, Lauria, G, Santoro, L, Sartucci, F, Maritato, P, Scarpini, E, De Riz, M, Siciliano, G, Cafforio, G, Versano, A, Terenghi, F, Vita, Giuseppe, and Mazzeo, Anna

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, SF-36, Affect (psychology), Disability assessment, Disability Evaluation, Physical medicine and rehabilitation, Quality of life, Older patients, Surveys and Questionnaires, Humans, Medicine, In patient, Child, Severe disability, Aged, Aged, 80 and over, business.industry, General Neuroscience, neuropathy, dysability, Peripheral Nervous System Diseases, Middle Aged, humanities, Child, Preschool, Quality of Life, Physical therapy, Female, Settore MED/26 - Neurologia, Neurology (clinical), business, Normative sample
Abstract

Neuropathy can severely affect patients' quality of life (QoL), causing disability and decreased motor efficiency while modifying their perception of the external environment. We performed a large, multi-perspective, and multi-measurement assessment using validated clinical measurements of disability and QoL. With regard to general disability, more than 10% of patients needed assistance to walk. With regard to arm disability, about 10% of patients had severe disability defined as impairment in carrying out simple tasks. General disability was similar both in polyneuropathic and multi-neuropathic groups, but arm disability appeared more severe in multi-neuropathic patients. QoL profiles were highly deteriorated in our sample with respect to the Italian normative sample. All age brackets were highly impaired except for older patients for whom the QoL picture was only mildly impaired with respect to Italian norms. We believe that our study provides reliable data on QoL in patients with neuropathies and that it may represent a quantitative step forward in understanding the disability of patients with neuropathy.

Published
2005

94. Blood pressure control and comorbidity in a nephrology clinic

Author

Triolo, L., Maria Sofia Cattaruzza, Sicoli, R., Ansali, F., Malaguti, M., Osborn, J., and Biagini, M.

Subjects
Male, Aging, Blood Pressure, Comorbidity, Middle Aged, elderly, Ambulatory Care Facilities, Nephrology, Chronic Disease, Hypertension, chronic kidney disease, comorbidity, diabetes mellitus, hypertension, proteinuria, Diabetes Mellitus, Humans, Female, Kidney Diseases, Referral and Consultation, Aged
Abstract

Many patients with established hypertension have poorly controlled blood pressure (BP). We studied demographic and clinical characteristics related to hypertension and analyzed the relationships between BP control and comorbidity.This study was based on 414 consecutive hypertensive out-patients referred to our nephrology clinic. We recorded systolic and diastolic BP, age, gender, body mass index, total cholesterol, family history of hypertension, glomerular filtration rate (GFR), 24-hr proteinuria, diabetes, coronary artery disease, smoking habits and antihypertensive drug treatment. BP control was considered optimal if BP was130/80 mmHg in patients with diabetes or chronic kidney disease (CKD), if BP was125/75 mmHg in CKD with proteinuria1 g/24 hr and if BP was140/90 mmHg in patients with no comorbidity. Multivariate logistic regression analysis was used to investigate the association between BP control and predictors.Only 26.6% of patients had adequately controlled BP. Eighty-five percent of patients aged65 yrs had uncontrolled systolic hypertension. Univariate analysis showed a significant association between poor BP control and age65 yrs, family history of hypertension, diabetes, CKD with or without proteinuria1 g/24 hr and total cholesterol220 mg/dL. Multivariate logistic regression showed that age65 yrs, diabetes and CKD with or without proteinuria1 g/24 hr were significantly and independently associated with poor BP control.Inadequate hypertension control is a common cause for referral to our out-patient nephrology clinic. Our data confirm that elderly patients, diabetic patients and nephropathic patients are difficult to treat; and therefore, deserve the highest quality clinical attention.

Published
2004

97. Pathophysiology and clinical studies in CKD 1-5

Author

Gerakis, A., primary, Halapas, A., additional, Chrissoheris, M., additional, Giatras, I., additional, Andritsou, R., additional, Nikolaou, I., additional, Bouboulis, N., additional, Pattakos, E., additional, Spargias, K., additional, Kalaitzidis, R., additional, Karasavvidou, D., additional, Pappas, K., additional, Katatsis, G., additional, Tatsioni, A., additional, Siamopoulos, K., additional, de Borst, M. H., additional, Hajhosseiny, R., additional, Tamez, H., additional, Wenger, J., additional, Thadhani, R., additional, Goldsmith, D. J., additional, Zanoli, L., additional, Rastelli, S., additional, Marcantoni, C., additional, Blanco, J., additional, Tamburino, C., additional, Castellino, P., additional, Larsen, T., additional, Jensen, J., additional, Bech, J., additional, Pedersen, E., additional, Mose, F., additional, Leckstrom, D., additional, Bhuvanakrishna, T., additional, McGrath, A., additional, Goldsmith, D., additional, Muras, K., additional, Masajtis-Zagajewska, A., additional, Nowicki, M., additional, Rayner, H. C., additional, Baharani, J., additional, Smith, S., additional, Suresh, V., additional, Dasgupta, I., additional, Zarzoulas, F., additional, Balafa, O., additional, Di Lullo, L., additional, Floccari, F., additional, Rivera, R., additional, Gorini, A., additional, Malaguti, M., additional, Barbera, V., additional, Granata, A., additional, Santoboni, A., additional, Luczak, M., additional, Formanowicz, D., additional, Pawliczak, E., additional, Wanic-Kossowska, M., additional, Koziol, L., additional, Figlerowicz, M., additional, Bommer, J., additional, Fliser, M., additional, Roth, P., additional, Saure, D., additional, Vettoretti, S., additional, Alfieri, C., additional, Floreani, R., additional, Regalia, A., additional, Bonanomi, C., additional, Meazza, R., additional, Magrini, F., additional, Messa, P., additional, Jankowski, V., additional, Zidek, W., additional, Joachim, J., additional, Lee, K., additional, Hwang, I. H., additional, Lee, S. B., additional, Lee, D. W., additional, Kim, I. Y., additional, Kwak, I. S., additional, Seong, E. Y., additional, Shin, M. J., additional, Rhee, H., additional, Yang, B. Y., additional, Dattolo, P., additional, Michelassi, S., additional, Sisca, S., additional, Allinovi, M., additional, Amidone, M., additional, Mehmetaj, A., additional, Pizzarelli, F., additional, Filiopoulos, V., additional, Manolios, N., additional, Hadjiyannakos, D., additional, Arvanitis, D., additional, Panagiotopoulos, K., additional, Vlassopoulos, D., additional, Kim, J. S., additional, Han, B. G., additional, Choi, S. O., additional, Yang, J. W., additional, Shojai, S., additional, Babu, A., additional, Boddana, P., additional, Dipankar, D., additional, Alvarado, R., additional, Garcia-Pino, G., additional, Ruiz-Donoso, E., additional, Chavez, E., additional, Luna, E., additional, Caravaca, F., additional, Geiger, H., additional, Buttner, S., additional, Lv, L.-L., additional, Cao, Y., additional, Zheng, M., additional, Liu, B.-C., additional, Kouvelos, G. N., additional, Raikou, V. D., additional, Arnaoutoglou, E. M., additional, Milionis, H. J., additional, Boletis, J. N., additional, Matsagkas, M. I., additional, Raiola, I., additional, Trepiccione, F., additional, Pluvio, M., additional, Raiola, R., additional, Capasso, G., additional, Kaykov, I., additional, Kukoleva, L., additional, Zverkov, R., additional, Smirnov, A., additional, Hammami, S., additional, Frih, A., additional, Hajem, S., additional, Hammami, M., additional, and Wan, L., additional

Published
2013
Full Text
View/download PDF

98. Bio-Markers and Cardiorenal Disease: Prognostic and Clinical Relevance

Author

Di Lullo, L., primary, Floccari, F., additional, Rivera, R., additional, Barbera, V., additional, Faiola, R., additional, Feliziani, C., additional, Granata, A., additional, De Pascalis, A., additional, Logias, F., additional, Fiorini, F., additional, Timio, M., additional, Malaguti, M., additional, and Santoboni, A., additional

Published
2012
Full Text
View/download PDF

100. Clinical Nephrology - Lab methods and other markers

Author

Kleophas, W., primary, Bieber, B., additional, Robinson, B., additional, Duttlinger, J., additional, Fliser, D., additional, Lonneman, G., additional, Rump, L., additional, Pisoni, R., additional, Port, F., additional, Reichel, H., additional, Daniela, R., additional, Ciocalteu, A., additional, Checherita, I. A., additional, Peride, I., additional, Spataru, D. M., additional, Niculae, A., additional, Laetitia, K., additional, Amna, K., additional, Laurence, D., additional, Aoumeur, H.-A., additional, Flamant, M., additional, Haymann, J.-P., additional, Letavernier, E., additional, Vidal-Petiot, E., additional, Boffa, J.-J., additional, Vrtovsnik, F., additional, Bianco, F., additional, Pessolano, G., additional, Carraro, M., additional, Panzetta, G. O., additional, Ebert, N., additional, Gaedeke, J., additional, Jakob, O., additional, Kuhlmann, M., additional, Martus, P., additional, Van der Giet, M., additional, Scha  ner, E., additional, Khan, I., additional, Law, Y., additional, Turgutalp, K., additional, Ozhan, O., additional, Gok Oguz, E., additional, Kiykim, A., additional, Donadio, C., additional, Hatmi, Z. N., additional, Mahdavi-Mazdeh, M., additional, Morales, E., additional, Gutierrez-Millet, V., additional, Rojas-Rivera, J., additional, Huerta, A., additional, Gutierrez, E., additional, Gutierrez-Solis, E., additional, Polanco, N., additional, Caro, J., additional, Gonza z, E., additional, Praga, M., additional, Marco Mayayo, M., additional, Valdivielso, J., additional, Marti  z, M., additional, Fernaez Giraez, E., additional, Obrador, G., additional, Olvera, N., additional, Ortiz de la Pe, D., additional, Gutie ez, V., additional, Villa, A., additional, Redal-Baigorri, B., additional, Sombolos, K., additional, Tsakiris, D., additional, Boletis, J., additional, Vlahakos, D., additional, Siamopoulos, K., additional, Vargiemezis, V., additional, Nikolaidis, P., additional, Iatrou, C., additional, Dafnis, E., additional, Argyropoulos, C., additional, Xynos, K., additional, Schock-Kusch, D., additional, Shulhevich, Y., additional, Geraci, S., additional, Hesser, J., additional, Stsepankou, D., additional, Neudecker, S., additional, Koenig, S., additional, Hoecklin, F., additional, Pill, J., additional, Gretz, N., additional, Schweda, F., additional, Schreiber, A., additional, Kudo, K., additional, Konta, T., additional, Choi, S. O., additional, Kim, J. S., additional, Kim, M. K., additional, Yang, J. W., additional, Han, B. G., additional, Delanaye, P., additional, Cavalier, E., additional, Masson, I., additional, Mehdi, M., additional, Nicolas, M., additional, Lambermont, B., additional, Dubois, B., additional, Damas, P., additional, Krzesinski, J.-M., additional, Morel, J., additional, Lautrette, A., additional, Christophe, M., additional, Gagneux-Brunon, A., additional, Anne, F., additional, Fre (C)ric, L., additional, Bevc, S., additional, Ekart, R., additional, Hojs, R., additional, Gorenjak, M., additional, Puklavec, L., additional, Hashimoto, N., additional, Suzuki, A., additional, Mitsumoto, K., additional, Shimizu, M., additional, Niihata, K., additional, Kawabata, A., additional, Sakaguchi, Y., additional, Hayashi, T., additional, Shoji, T., additional, Okada, N., additional, Tsubakihara, Y., additional, Hamano, T., additional, Nakano, C., additional, Fujii, N., additional, Obi, Y., additional, Mikami, S., additional, Inoue, K., additional, Matsui, I., additional, Isaka, Y., additional, Rakugi, H., additional, Edvardsson, V., additional, Siguron, B., additional, Thorsteinsdottir, M., additional, Palsson, R., additional, Matsumoto, J., additional, Miyazaki, N., additional, Murata, I., additional, Yoshida, G., additional, Morishita, K., additional, Ushikoshi, H., additional, Nishigaki, K., additional, Ogura, S., additional, Minatoguchi, S., additional, Werneke, U., additional, Ott, M., additional, Salander-Renberg, E., additional, Taylor, D., additional, Stegmayr, B., additional, Surel, S., additional, Wenzlova, M., additional, Silva Junior, G., additional, Vieira, A. P., additional, Couto Bem, A., additional, Alves, M., additional, Torres, A., additional, Meneses, G., additional, Martins, A., additional, Liborio, A., additional, Daher, E., additional, Gluhovschi, G., additional, Modilca, M., additional, Daminescu, L., additional, Gluhovschi, C., additional, Velciov, S., additional, Petrica, L., additional, Gadalean, F., additional, Balgradean, C., additional, Schmeiser, H. H., additional, Kolesnyk, M., additional, Stepanova, N., additional, Surzhko, L., additional, Stashevska, N., additional, Filiopoulos, V., additional, Hadjiyannakos, D., additional, Arvanitis, D., additional, Panagiotopoulos, K., additional, Vlassopoulos, D., additional, Kaesler, N., additional, Schettgen, T., additional, Magdeleyns, E., additional, Brandenburg, V., additional, Vermeer, C., additional, Floege, J., additional, Kr, T., additional, Randone, O., additional, Ferraresi, M., additional, Aroasio, E., additional, Depascale, A., additional, Scognamiglio, S., additional, Consiglio, V., additional, Piccoli, G. B., additional, Jensen, L. V., additional, Lizakowski, S., additional, Rutkowski, P., additional, Tylicki, L., additional, Renke, M., additional, Sulikowska, B., additional, Donderski, R., additional, Bednarski, R., additional, Heleniak, Z., additional, Przybylska, M., additional, Manitius, J., additional, Rutkowski, B., additional, Bobrova, L., additional, Kozlovskaya, N., additional, Kanayama, K., additional, Hasegawa, M., additional, Kitagawa, F., additional, Ishii, J., additional, Yuzawa, Y., additional, Tanaka, K., additional, Sakai, K., additional, Hara, S., additional, Suzuki, Y., additional, Tanaka, Y., additional, Aikawa, A., additional, Hinoshita, F., additional, Hamano, N., additional, Sasaki, E., additional, Kato, A., additional, Katsuki, T., additional, Katsuma, A., additional, Imai, E., additional, Shibata, M., additional, Tada, M., additional, Shimbo, T., additional, Kikuchi, Y., additional, Oka, S., additional, Muramatsu, T., additional, Yanagisawa, N., additional, Fukutake, K., additional, Yamamoto, Y., additional, Ajisawa, A., additional, Tsuchiya, K., additional, Nitta, K., additional, Ando, M., additional, Liang, X., additional, Wang, P., additional, Liu, Z., additional, Zhao, Z., additional, Luyckx, V., additional, Bowker, S., additional, Miekle, A., additional, Toth, E., additional, Heguilen, R., additional, Malvar, A., additional, Hermes, R., additional, Cohen, L., additional, Muguerza, G., additional, Lococo, B., additional, Bernasconi, A., additional, Loboda, O., additional, Dudar, I., additional, Krot, V., additional, Alekseeva, V., additional, Ichinose, M., additional, Sasagawa, N., additional, Toyama, K., additional, Saito, A., additional, Kayamori, Y., additional, Kang, D., additional, Kim, H. W., additional, Yoshioka, K., additional, Hara, M., additional, Ohashi, K., additional, Maksudova, A., additional, Khalfina, T., additional, Cuoghi, A., additional, Bellei, E., additional, Caiazzo, M., additional, Bergamini, S., additional, Palladino, G., additional, Monari, E., additional, Tomasi, A., additional, Loiacono, E., additional, Camilla, R., additional, Dapr, V., additional, Morando, L., additional, Gallo, R., additional, Peruzzi, L., additional, Conrieri, M., additional, Bianciotto, M., additional, Bosetti, F. M., additional, Coppo, R., additional, DI Lullo, L., additional, Floccari, F., additional, Rivera, R., additional, Granata, A., additional, Faiola, R., additional, Feliziani, C., additional, Villani, A., additional, Malaguti, M., additional, Santoboni, A., additional, Kyriaki, K., additional, Droulias, J., additional, Bogdanova, M., additional, Rameev, V. V., additional, Simonyan, A. H., additional, Kozlovskaya, L. V., additional, Altiparmak, M. R., additional, Trabulus, S., additional, Akalin, N., additional, Yalin, A. S., additional, Esenkaya, A., additional, Yalin, S. F., additional, Serdengeae(C), K., additional, Arita, D., additional, Cunha, T., additional, Perez, J., additional, Sakata, M., additional, Arita, L., additional, Nogueira, M., additional, Jara, Z., additional, Souza, N., additional, Casarini, D., additional, Metzger, M., additional, Vallet, M., additional, Karras, A., additional, Froissart, M., additional, Stengel, B., additional, Houillier, P., additional, Paul, K., additional, Kretzschmar, D., additional, Yilmaz, A., additional, Ba hlein, B., additional, Titze, S., additional, Figulla, H.-R., additional, Wolf, G., additional, Busch, M., additional, Korotchaeva, Y., additional, Gordovskaya, N., additional, Kozlovskaya, L., additional, Ng, K. P., additional, Sharma, P., additional, Stringer, S., additional, Jesky, M., additional, Dutton, M., additional, Ferro, C., additional, Cockwell, P., additional, Moon, S. J., additional, Lee, S. C., additional, Yoon, S. Y., additional, Lee, J. E., additional, Han, S. J., additional, Anna, B., additional, Kirsch, T., additional, Svjetlana, L., additional, Joon-Keun, P., additional, Jan, B., additional, Johanna, K., additional, Haller, H., additional, Haubitz, M., additional, Smirnov, A., additional, Kayukov, I., additional, Rafrafi, N., additional, Degtereva, O., additional, Dobronravov, V., additional, Koch, M., additional, Stefan, H., additional, Dika, G., additional, Antoine, M.-H., additional, Husson, C., additional, Kos, J., additional, Milic, M., additional, Fucek, M., additional, Cvoriocec, D., additional, Bourgeade, M.-F., additional, Nortier, J. L., additional, Jelakovic, B., additional, Nawal, E. H., additional, Naoufal, M., additional, Nabila, M., additional, Fadwa, E. M., additional, Salma, E. K., additional, Nisrine, B., additional, Mohamed, Z., additional, Guislaine, M., additional, Mohamed Gharbi, B., additional, Benyounes, R., additional, Sotila, G. G., additional, Sorin, R., additional, Irina Magdalena, D., additional, Roxana, C., additional, Claudia, R., additional, Correa Barcellos, F., additional, Hallal, P. H., additional, Bohlke, M., additional, Boscolo Del Vechio, F., additional, Reges, A., additional, Santos, I., additional, Mielke, G., additional, Fortes, M., additional, Antunez, B., additional, Laganovic, M., additional, Vukovic Lela, I., additional, Karanovic, S., additional, Seric, J., additional, Premuic, V., additional, Fitrek, M., additional, Fodor, L., additional, Meljkovic Vrkic, T., additional, Bansal, V., additional, Hoppensteadt, D., additional, and Fareed, J., additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results